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Ba c k g r o u n d: A reduction in the use of polybrominated diphenyl ethers (PBDEs) because of 
human health concerns may result in an increased use of and human exposure to organophosphate 
flame retardants (OPFRs). Human exposure and health studies of OPFRs are lacking.
oBjectives: We sought to define the degree of temporal variability in urinary OPFR metabolites in 
order to inform epidemiologic study design, and to explore a potential primary source of exposure by 
examining the relationship between OPFRs in house dust and their metabolites in urine.
Me t h o d s : Nine repeated urine samples were collected from 7 men over the course of 3 months 
and analyzed for bis(1,3-dichloro-2-propyl) phosphate (BDCPP) and diphenyl phosphate (DPP), 
metabolites of the OPFRs tris(1,3-dichloro-2-propyl) phosphate (TDCPP) and triphenyl phos-
phate (TPP), respectively. Intraclass correlation coefficients (ICCs) were calculated to characterize 
  temporal reliability. Paired house dust and urine samples were collected from 45 men.
re s u l t s: BDCPP was detected in 91% of urine samples, and DPP in 96%. Urinary BDCPP 
showed moderate-to-strong temporal reliability (ICC range, 0.55–0.72). ICCs for DPP were lower, 
but moderately reliable (range, 0.35–0.51). There was a weak [Spearman r (rS) = 0.31] but signifi-
cant (p = 0.03) correlation between urinary BDCPP and TDCPP concentrations in house dust 
that strengthened when nondetects (rS = 0.47) were excluded. There was no correlation between 
  uncorrected DPP and TPP measured in house dust ( rS < 0.1).
co n c l u s i o n s: Household dust may be an important source of exposure to TDCPP but not TPP. 
Urinary concentrations of BDCPP and DPP were moderately to highly reliable within individuals 
over 3 months.
key w o r d s : biomarker, epidemiology, exposure, human, TDCPP, triphenyl phosphate. Environ 
Health Perspect 121:580–585 (2013).  http://dx.doi.org/10.1289/ehp.1205907 [Online 5 March 
2013]
Flame retardant chemicals are commonly 
added to consumer products and raw materials 
to delay combustion and meet fire safety 
standards. Because many flame retardants are 
additive rather than chemically bonded with 
the material, over time they can leach out 
of the treated materials, which may result in 
human exposure through various pathways 
and routes. This includes ingestion, inhalation, 
and dermal contact with household dust, 
among other sources (Johnson et al. 2010; 
Stapleton et al. 2012; Watkins et al. 2012). 
Flame retardants such as poly  brominated 
diphenyl ethers (PBDEs) and others have 
received much attention lately, as widespread 
human exposure has been documented and 
concerns for health risks have increased based 
on recent reports from human and animal 
research (Birnbaum and Bergman 2010; 
DiGangi et al. 2010; Shaw et al. 2010). This 
has led to bans or voluntary phase-outs of 
several commercial PBDE mixtures from the 
marketplace in many countries. However, 
with the halted or reduced use of PBDEs 
throughout the world, there are new concerns 
regarding human exposure and possible health 
effects associated with the alternative flame 
retardants that may be increasingly used to 
replace PBDEs.
Of a number of available alternatives 
to PBDEs, the use of organophosphate 
flame retardants (OPFRs), such as the tri-
esters tris(1,3,-dichloro-2-propyl) phosphate 
(TDCPP) and triphenyl phosphate (TPP), are 
currently widespread and expected to increase 
(U.S. Environmental Protection Agency 
2005). TDCPP and TPP are used as additive 
flame retardants in polymers, resins, latexes, 
and foams; TPP is also used as a plasticizer 
and lubricant and in hydraulic fluids (van der 
Veen and de Boer 2012). The United States 
is likely the largest user of TDCPP and TPP, 
consuming between 4,500 and 22,700 metric 
tons of each chemical annually (van der Veen 
and de Boer 2012). However, data on human 
exposure and potential health risks related 
to OPFRs are lacking. We recently detected 
TDCPP and TPP in 96% and 98% of U.S. 
house dust samples analyzed, respectively, 
with concentrations similar to or greater 
than those measured for PBDEs in the same 
samples (Stapleton et al. 2009). TDCPP was 
detected in 15 of 26 samples of polyurethane 
foam collected from different types of residen-
tial furniture, and it was the most common 
flame retardant detected in infant products, 
in a recent survey (Stapleton et al. 2011). It 
was detected in 36% of 102 samples that were 
analyzed, at concentrations that accounted for 
approximately 4–5% of the foam by weight.
Limited animal studies suggest that cer-
tain OPFRs may be carcinogenic, neurotoxic, 
and/or reproductive toxicants (Dishaw et al. 
2011; van der Veen and de Boer 2012). As far 
as we are aware, our previous study reporting 
relationships of TDCPP and TPP in house 
dust with hormone levels and semen quality 
in men remains the only human study on 
these OPFRs to date (Meeker and Stapleton 
2010). More experimental animal and human 
epidemiology research is needed to determine 
potential health risks resulting from exposure 
to OPFRs.
Adequate assessment of exposure is a vital 
component for reducing measurement error 
in epidemiologic studies. Measurement error 
can be detrimental to the ability to detect 
potential associations between an exposure 
and health outcome with adequate power, 
accuracy, and precision. For flame retardants, 
measuring chemical concentrations in dust 
or relevant biomarkers in various biological 
specimens are two options for assessing expo-
sure in epidemiologic studies. Measurements 
of the parent compounds and/or metabolites 
can prove to be useful biomarkers of exposure. 
For OPFRs, metabolism can be quite rapid. 
Previous studies in rodents demonstrated that 
TDCPP and TPP were rapidly metabolized, 
and the primary metabolites identified were 
dialkyl metabolites, bis(1,3-dichloro-2-propyl) 
phosphate (BDCPP), and diphenyl phosphate 
(DPP), respectively (Lynn et al 1981; Nomeir 
et al 1981; Sasaki et al 1984). Furthermore, a 
recent study investigating the in vitro metabo-
lism of these same two OPFRs in human 
liver microsomes demonstrated that the pri-
mary metabolites in humans were also likely 
BDCPP and DPP (Cooper and Stapleton 
2012). We recently developed a method 
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to extract and measure BDCPP and DPP 
metabo  lites in human urine (Cooper et al. 
2011). In that study, nine randomly collected 
urine samples from nonoccupationally exposed 
adults all had detectable concentrations of 
both metabolites. Urinary concentrations of 
BDCPP ranged from 0.04 to 1.66 ng/mL, 
and DPP concentrations ranged from 0.15 to 
1.07 ng/mL. However, the method has yet 
to be applied to a larger study. Furthermore, 
because TDCPP and TPP are metabolized 
to BDCPP, DPP, and other metabolites and 
rapidly excreted, more information is needed 
on how variable urinary metabolite concen-
trations are within individuals over time. If 
TDCPP and TPP are persistent in house dust, 
and house dust is the primary source of expo-
sure, urinary metabolite concentrations may 
be relatively stable over time despite their short 
biological half-lives if individual time–activity 
patterns are consistent.
The goals of the present study were to 
a) characterize the distribution of urinary 
BDCPP and DPP in a population of U.S. 
men from an ongoing study; b) define the 
degree of temporal variability in these OPFR 
metabolites in order to inform exposure assess-
ment efforts in epidemiologic studies; and 
c) determine the relationship between OPFRs 
in house dust and their metabolites in urine 
as a first step in identifying possible sources, 
pathways, and routes important for human 
exposure. Identification of how exposure takes 
place is a critical step for risk management 
through effective exposure reduction strategies.
Methods
Study participants. The present study was 
conducted on a subset of men participating in 
an ongoing study of environmental factors in 
reproductive health. Details of subject recruit-
ment into the parent study have been previ-
ously described (Meeker et al. 2005, 2007). 
Briefly, men between 18 and 54 years of age 
were recruited from the Vincent Memorial 
Andrology laboratory at Massachusetts General 
Hospital and invited to participate in the study. 
Applicable requirements involving human sub-
jects were followed; institutional review board 
approval was obtained from each participating 
institution and all subjects provided written 
informed consent. Approximately 65% of eli-
gible men agreed to participate. Exclusionary 
criteria included prior vasectomy or current use 
of exogenous hormones.
We previously analyzed TDCPP and TPP 
concentrations in house dust collected from the 
homes of 50 randomly selected men partici-
pating in the parent study who were recruited 
between years 2002 and 2007 (Meeker and 
Stapleton 2010). For the present study, 45 of 
the 50 men had archived urine samples with 
enough volume to measure OPFR metabo-
lites to evaluate agreement between the 
concentrations of the parent chemical in house 
dust with its metabolite in urine. Dust and 
urine samples from the same men were typi-
cally collected within a month of one another, 
with a median of 14 days. A urine sample was 
collected at the clinic visit upon study recruit-
ment, and the participants were given prepaid 
shipping material and detailed instructions to 
send the vacuum bag that was in their home 
vacuum cleaner at the time to the research 
team for analysis.
The parent study also included a variability 
substudy, where a subset of men were recruited 
to provide 9 repeated urine samples over the 
course of 3 months (the approximate dura-
tion of spermatogenesis) in order to determine 
temporal variability of various exposure bio-
markers. A urine sample was collected on each 
of 3 repeated days in three separate cycles that 
were 1 or 2 months apart; upon enrollment 
into the variability study, men provided urine 
samples from days 1, 2, 3, 30, 31, 32, 91, 92, 
and 93. Seven of these men from the variability 
substudy were included in the present analysis. 
One of the seven men had 1 missing repeat 
urine sample, and 1 sample from a second man 
had insufficient volume for extraction. Thus, a 
total of 61 urine samples were analyzed from 
the variability substudy.
Urine analysis. Urine samples, which were 
collected in glass vials [either a 30 mL Qorpak 
vial (Qorpak, a division of Berlin Packaging, 
Bridgeville, PA) or a 25 mL Wheaton vial 
(Wheaton Industries, Millville, NJ)] and 
stored at –80°C, were analyzed for BDCPP 
and DPP as previously described (Cooper 
et al. 2011). Briefly, BDCPP and DPP were 
measured in urine samples using mixed-mode 
anion exchange solid phase extraction and a 
mass-labeled internal standard [deuterated 
(d10)-BDCPP and d10-DPP] with analysis 
by atmospheric pressure chemical ionization 
liquid chromatography–  tandem mass spec-
trometry. For quality assurance purposes, we 
evaluated BDCPP and DPP levels in labo-
ratory blanks (deionized water; n = 6) and 
ran 12 samples in duplicate. Recoveries of the 
internal quantification standards, d10-BDCPP 
and d10-DPP, averaged 88 ± 16% and 
89 ± 15%, respectively. BDCPP and DPP 
were present at very low levels in labora-
tory blanks and averaged 0.06 ± 0.05 ng and 
0.14 ± 0.09 ng, respectively. The method 
detection limit was calculated using three times 
the SD of the blanks normalized to the urine 
volume extracted, which was 32.7 pg/mL and 
55.3 pg/mL, for BDCPP and DPP respec-
tively. Specific gravity (SG) was measured in 
each urine sample before analysis using a digi-
tal handheld refractometer.
Dust analysis. Dust from participants’ 
household vacuum bags was sieved (150 μm 
screen) and analyzed for TDCPP and TPP 
as described in our previous report (Meeker 
and Stapleton 2010). Briefly, 0.3–0.5 g 
of sieved dust was extracted in stainless 
steel cells with a 50:50 vol:vol mixture of 
dichloromethane:hexane using pressurized fluid 
extraction (ASE 300; Dionex Inc., Sunnyvale, 
CA). Final extracts were reduced in volume 
to approximately 1.0 mL using an automated 
nitrogen evaporation system (Turbo Vap II; 
Zymark Inc., Hopkinton, MA) and were 
purified by elution through a glass column 
containing 4.0 g of 6% deactivated alumina. 
The final extract was then reduced in volume 
to 0.5 mL before gas chromatography–  mass 
spectrometry (GC/MS) analysis. Samples were 
analyzed using GC/MS operated in either 
electron impact mode (GC/EI-MS) for TPP, 
or electron capture negative ionization mode 
(GC/ECNI-MS) for TDCPP. TDCPP was 
quantified by monitoring m/z 319 and 317, 
and TPP was quantified by monitoring m/z 
326 and 325. As further confirmation, all ion 
ratios were monitored and were within 20% 
of their expected values as compared with 
  authentic standards.
As part of our quality assurance criteria, 
we examined levels of these specific analytes 
in laboratory blanks (sodium sulfate and sol-
vent only, n = 4), replicate samples (n = 3), 
and in matrix spikes (n = 3). Sample measure-
ments were blank corrected by subtracting 
the average level measured in the laboratory 
blanks. Blank levels for TDCPP and TPP were 
11.7 ± 6.6 and 15.7 ± 11.9 ng, respectively. 
Method detection limits were calculated as 
three times the SD of the blank levels. Matrix 
spikes were prepared by adding between 25 
and 100 ng of TDCPP and TPP to the ASE 
cells [stainless steel cells used on the ASE 
300 (Dionex Inc.)] filled with sodium sulfate 
powder. Matrix spikes were extracted using 
the same method used for dust and exam-
ined for percent recovery using 50 ng of 13C 
chlorinated diphenyl ether 141 as an internal 
standard. Recoveries averaged 86 ± 7% and 
89 ± 2% for TDCPP and TPP, respectively.
Statistical analysis. Statistical analysis 
was carried out using SAS version 9.2 (SAS 
Institute Inc., Cary, NC). Distributions of 
urinary BDCPP and DPP concentrations, 
along with dust concentrations of TDCPP 
and TPP, were tabulated. Graphs were con-
structed to visually and qualitatively compare 
urinary metabolite concentrations over time 
within and between subjects. To quantitatively 
assess between- and within-person variability 
in urinary BDCPP and DPP concentrations, 
intraclass correlation coefficients (ICCs) and 
their 95% confidence intervals (CIs) were cal-
culated using mixed random effects models in 
SAS PROC MIXED (Hankinson et al. 1995; 
Rosner 2000). ICC is a measure of the reli-
ability of repeated measures over time, defined 
as the ratio of between-subject variance and 
total variance. ICC ranges from zero to one, Meeker et al.
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with values near zero indicating poor reli  ability 
and values near one indicating high reliability 
(Rosner 2000).
In addition to calculating ICCs, we also 
conducted a sensitivity analysis to evaluate 
how well OPFR metabolite concentrations 
from a single urine sample (the “predicted” or 
“surrogate” value) could correctly classify men 
into the highest exposure category based on 
their 3-month geometric mean (GM) concen-
tration (the “observed” or “true” value) calcu-
lated from the nine repeated samples (Hauser 
et al. 2004; Mahalingaiah et al. 2008; Meeker 
et al. 2005). In this analysis, the seven men in 
the variability study were first categorized into 
exposure groups for both BDCPP and DPP 
based on their 3-month GM concentrations 
using three different cutoffs: a) men with the 
four highest 3-month exposure levels (> 43rd 
percentile), b) men with the three highest 
3-month exposure levels (> 57th percentile), 
or c) men with the two highest 3-month expo-
sure levels (> 71st percentile). Men were then 
ranked by exposure for each individual time 
point (e.g., day 1, 2, 3, 30) based on the con-
centrations measured in that individual sam-
ple. A contingency table was then constructed 
for each time point comparing predicted and 
observed categories. Contingency tables from 
all 9 time points were then combined into a 
single table, where sensitivity, specificity, posi-
tive predictive value, and negative predictive 
value were calculated for each metabolite and 
for each of the three category cutoff schemes.
Finally, scatter plots were constructed 
to assess the relationship between dust and 
urine metabolite concentrations. Spearman 
rank correlations (rS) were then calculated to 
evaluate the relationships between concen-
trations of TDCPP and TPP in house dust 
and concen  trations of their metabolites in 
urine from the same men from their clinic 
visit at study entry. For urinary metabolites, all 
analyses were con  ducted for both uncorrected 
concentrations and concentrations corrected 
for specific gravity using the following formula:
 P c = P × [(1.024–1)/(SG–1)],  [1]
where Pc is the SG-corrected metabolite 
concentration (in nanograms per milliliter), 
P is the observed metabolite concentration 
(in nanograms per milliliter), and SG is the 
specific gravity of the urine sample (Boeniger 
et al. 1993).
Results
Overall, of the 106 samples we analyzed for 
the two OPFR metabolites, BDCPP was 
detected in 96 samples (91%), and DPP was 
detected in 102 samples (96%). Table 1 shows 
the distribution of BDCPP and DPP concen-
trations in urine, as well TDCPP and TPP 
in dust, from the 45 men who contributed a 
single sample of both matrices. Distributions 
of all analytes spanned several orders of mag-
nitude and were highly right-skewed. BDCPP 
and DPP in urine were moderately correlated 
with one another (rS = 0.54; p < 0.05).
Figure 1 shows concentrations of BDCPP 
and DPP measured in nine repeated samples 
collected from seven men who participated 
in the variability substudy over the course of 
3 months (two men were missing a sample at 
one of the time points; n = 61). For BDCPP 
(Figure 1A), one man had noticeably higher 
concentrations for 8 of the 9 sample days, 
whereas there appeared to be more overlap in 
DPP concentrations between men over time 
(Figure 1B). Table 2 displays ICCs for these 
data. BDCPP showed moderate-to-strong tem-
poral reliability depending on whether concen-
trations were SG-corrected and/or nondetect 
samples were excluded (ICC range, 0.55–0.72) 
(Rosner 2000). ICCs for DPP were lower but 
moderately reliable (range, 0.35–0.51).
Results from our sensitivity analysis for the 
ability of a single sample to correctly classify 
men as being more highly exposed based on 
their 3-month GMs (not SG corrected) are 
shown in Table 3. Both metabolites showed 
high sensitivities (range, 0.70–0.86), with 
DPP showing somewhat greater agreement 
and more consistency between classification 
approaches compared with BDCPP. Results 
were similar when calculating sensitivity, speci-
ficity, positive predictive value, and negative 
predictive value using SG-corrected concentra-
tions (data not shown).
Figure 2 displays scatter plots of the 
relationship between uncorrected urinary 
BDCPP and DPP concentrations and pre-
viously measured concentrations of TDCPP 
and TPP, respectively, in house dust (n = 45). 
Uncorrected urinary BDCPP was weakly 
(rS = 0.31) but significantly (p = 0.03) cor-
related with TDCPP concentrations in house 
dust (Figure 2A). This correlation weak-
ened when using SG-corrected BDCPP 
Table 1. Distribution (GM and selected percentiles) of urinary DBCPP and DPP concentrations (ng/mL), 
and paired TDCPP and TPP concentrations (ng/g) in house dust (n = 45).
Percentile
Variable Percent NDa GM 10th 25th 50th 75th 90th 95th Maximum
Urine (ng/mL)
BDCPP  9 0.13 ND 0.03 0.12 0.27 0.89 1.89 25.0
DPP  4 0.31 0.07 0.14 0.27 0.75 1.64 2.65 9.84
Dust (ng/g)
TDCPP 4 1,580 181 891 1,620 2,450 14,390 47,000 56,080
TPP  2 6,836 600 2,925 6,000 9,170 180,450 319,820 1,798,000
ND, nondetect.
aRate based on all 106 urine samples analyzed.
Figure 1. Concentrations (ng/mL) in urine from repeated samples collected from seven men over a 3-month period. (A) BDCPP; (B) DPP. Colors represent individual men.
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concentrations (rS = 0.25; p = 0.10). There 
was no correlation between uncorrected 
(rS = 0.04; p = 0.8) (Figure 2B) or SG-corrected 
(rS = 0.03; p = 0.8) DPP and TPP measured 
in house dust. When excluding seven nonde-
tects (not shown), the correlation of TDCPP 
with BDCPP increased to 0.47 (p = 0.003). 
However, removing three non  detects did not 
improve the correlation between TPP and 
DPP (rS = 0.05). Finally, we calculated correla-
tions when stratifying by time between collec-
tion of urine and dust samples, but correlations 
did not improve when limiting the analysis to 
samples collected within 2 weeks (n = 22) or 
within 1 week (n = 10) of one another.
Discussion
BDCPP and DPP were detected in nearly all 
urine samples analyzed from a study of expo-
sure to environmental chemicals and repro-
ductive health among men from the Boston, 
Massachusetts, area. This confirms the previous 
findings from our method development study 
that found detectable levels of both DBCPP 
and DPP in all nine samples randomly col-
lected from adults in North America (Cooper 
et al. 2011). In both that study and in the 
present analysis, a very broad range of concen-
trations spanning four orders of magnitude 
were found, suggesting exposure to OPFRs is 
widespread but may be highly variable among 
U.S. adults.
Although toxicokinetic information on 
TDCPP and TPP is limited, studies using 
rat and human liver microsomes suggest that 
TDCPP and TPP are metabolized rapidly to 
diesters (e.g., BDCPP and DPP, respectively) 
and other metabolites (Cooper and Stapleton 
2012; Lynn et al. 1981; Nomeir et al. 1981; 
Sasaki et al. 1984). Thus, the half-lives of 
the parent compounds in blood, and of their 
metabolites in urine, are likely very short, on 
the order of several hours. The development 
of exposure biomarkers of OPFRs that can 
be measured in blood or urine is a significant 
step toward improving the existing data on 
human health risk in relation to these chemi-
cals. However, as with other non  persistent 
environmental contaminants, if a single urine 
sample is used to define individual exposure 
in an epidemiologic study, knowledge of its 
temporal variability is needed to determine 
whether the measure is reliable over a period 
of time commensurate with the development 
of the outcome measure(s) of interest in order 
to minimize exposure measurement error and 
misclassification. To address this, we calcu-
lated ICCs and sensitivity to determine the 
reliability of BDCPP and DPP over the course 
of 3 months.
In the ICC analysis, there was moder-
ate reliability for DPP (ICC = 0.4–0.5), and 
moderate to strong reliability for BDCPP 
(ICC = 0.6–0.7). The ICCs for both metabo-
lites were higher than other urinary biomarkers 
of nonpersistent chemicals that have been mea-
sured in overlapping groups of men from the 
same cohort (Hauser et al. 2004; Mahalingaiah 
et al. 2008; Meeker et al. 2005), especially for 
chemicals resulting from exposure primarily 
through diet. For example, there were con-
siderably weaker ICCs in the ongoing study 
for bisphenol A (BPA; ICC = 0.2), mono-2-
ethylhexyl phthalate (MEHP; ICC = 0.3), and 
3,5,6-trichloro-  2-pyridinol (TCPY, a metabo-
lite of the organophosphate insecticides chlo-
rpyrifos and chlorpyrifos-methyl; ICC = 0.2). 
Thus, the higher ICCs for OPFR metabolites 
may indicate direct and stable sources, such as 
indoor dust, may be significant contributors to 
exposure. For BDCPP, one man had notably 
higher concentrations on most sample days, 
suggesting a consistent source of exposure for 
that participant. This participant was also the 
only variability subject for whom we had mea-
sured OPFR dust concentrations to compare 
with urinary metabolites at study entry. He 
Table 2. ICCs (95% CIs) for uncorrected and SG-corrected urinary BDCPP and DPP concentrations.
Urinary metabolite
All samplesa Excluding nondetectsb
Uncorrected SG-Corrected Uncorrected SG-Corrected
BDCPP 0.62 (0.40, 0.80) 0.55 (0.31, 0.77) 0.70 (0.50, 0.84) 0.72 (0.53, 0.85)
DPP 0.36 (0.18, 0.60) 0.35 (0.17, 0.59) 0.51 (0.32, 0.70) 0.50 (0.29, 0.70)
an = 106 samples from 51 men. bn = 102 samples from 48 men for DPP, n = 96 samples from 44 men for BDCPP.
Table 3. Sensitivity and specificity analysis for the ability of a single urine measurement to correctly clas-
sify a high exposure group among 7 men according to 3-month GM metabolite concentration.
Exposure classification Sensitivity Specificity PPV NPV
Highest 4 of 7
BDCPP (> 0.165 ng/mL) 0.75 0.64 0.75 0.64
DPP (> 0.545 ng/mL 0.86 0.65 0.77 0.77
Highest 3 of 7
BDCPP (> 0.175 ng/mL) 0.70 0.56 0.56 0.70
DPP (> 1.15 ng/mL) 0.81 0.79 0.76 0.84
Highest 2 of 7
BDCPP (> 0.190 ng/mL) 0.83 0.60 0.47 0.90
DPP (> 1.99 ng/mL) 0.83 0.86 0.71 0.93
Abbreviations: PPV, positive predictive value; NPV, negative predictive value. Concentrations not corrected for SG.
Figure 2. Relationship between house dust OPFR concentrations (ng/g of dust) and uncorrected urinary metabolite concentrations (ng/mL) for 45 study 
  participants with paired samples. (A) TDCPP and BDCPP (rS = 0.31, p = 0.03). (B) TPP and DPP (rS = 0.04, p = 0.8).
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had one of the higher concentrations of both 
dust TDCPP and urinary BDCPP among the 
45 men with paired dust and urine samples 
(14,391 ng/g TDCPP, 5th highest dust con-
centration of the 45 men with paired data; 
0.89 ng/mL BDCPP; also 5th highest uri-
nary concentration among the 45 men with 
paired data).
Both metabolites showed high sensitivities 
for a single urine sample to predict high expo-
sure groups based on 3-month GM concentra-
tions. For DPP, which did not perform as well 
in the ICC analysis compared with BDCPP, 
this may indicate that there may be signifi-
cant within-person variability in concentra-
tions over time, but that DPP concentrations 
among the most highly exposed individuals 
tend to remain among the highest relative to 
other individuals over the course of 3 months. 
However, it should be noted that the sensitiv-
ity analysis included samples from only seven 
men and that results may be unstable because 
of the relatively small sample size. Future stud-
ies should assess the temporal variability of 
these and other OPFR markers of exposure in 
a larger number of participants.
Dust in the home and in other environ-
ments has been shown to be a major source 
of exposure for other flame retardants such as 
PBDEs, with hand-to-mouth contact repre-
senting one of the primary exposure pathways 
(Johnson et al. 2010; Stapleton et al. 2012; 
Watkins et al. 2012). However, empirical data 
on potential sources, pathways, and routes of 
exposure to OPFRs are lacking. In our com-
parison of 45 paired house dust and urine 
samples, BDCPP concentrations in urine were 
moderately but significantly correlated with 
TDCPP concentrations in house dust. Thus, 
house dust may be an important source of 
exposure to TDCPP among adult men. The 
lack of a very strong correlation between house 
dust and urinary metabolite concentrations is 
not unexpected, given the rapid metabolism 
of TDCPP and moderate-to-strong temporal 
reliability in BDCPP concentrations. Other 
micro  environments containing TDCPP, such 
as workplaces, may also be significant contrib-
utors to TDCPP exposure (and, subsequently, 
urinary BDCPP concentrations) as suggested 
in a recent Belgian study that found that dust 
concentrations of TDCPP were much greater 
in certain work environments compared 
with house dust (Van den Eede et al. 2011). 
However, it should be noted that TDCPP 
concentrations in house dust from Belgium 
are likely significantly lower than those found 
in house dust from the United States. Future 
studies should be designed to further deter-
mine sources, pathways, and routes of expo-
sure to OPFRs (e.g., vehicles, work, school, 
daycare), especially among children because 
they experience greater doses per body weight, 
typically have greater contact with house 
dust, and frequent hand-to-mouth contact 
and are at sensitive stages of rapid growth 
and development. Research is also needed 
on the variability of OPFR concentrations in 
dust samples over time within a given micro-
environment, and whether OPFR metabolites 
are present in the environment and contribute 
to urinary concentrations.
We found no correlation between TPP 
in house dust and DPP in urine. This sug-
gests that TPP in house dust may not be a 
primary source of exposure among adult men. 
As opposed to halogenated OPFRs such as 
TDCPP, which tend to be primarily used 
as flame retardants, non  derivatized alkyl 
phosphates such as TPP may be predomi-
nantly used as plasticizers and lubricants or in 
other applications (van der Veen and de Boer 
2012). These different and diverse uses may 
result in sources and pathways of exposure 
that are quite unlike those for chemicals that 
are used primarily as flame retardants. In 
addition, TPP has a higher vapor pressure 
than TDCPP, so it is possible that inhala-
tion of TPP in indoor air may play a more 
significant role in total exposure compared 
with TDCPP and other less volatile flame 
retardants. Other possibilities for the lack of 
correlation between TPP and DPP in our 
data include the potential for other chemicals 
to be metabolized to DPP, the potential for 
exposure to DPP directly if DPP is widely 
used in other applications (Makiguchi et al. 
2011), or after environmental degradation 
of TPP to DPP and potential interindividual 
differences in exposure profiles, scenarios, or 
toxico  kinetics. Differences in toxicokinetics 
between two persons with the same level of 
exposure could result in significant differ-
ences in the amount of a specific metabo  lite 
excreted in urine. Circumstances of sample 
collection may also contribute to the lack of 
correlation between TPP and DPP, and may 
have limited the strength of the correlation 
we calculated between TDCPP and BDCPP. 
For example, dust samples were obtained 
from participants’ vacuum bags as opposed 
to researcher-collected samples, and the time 
between collection of dust and urine samples 
varied between participants. However, limit-
ing the analysis to samples collected closer 
together in time did not improve the strength 
of the correlation between dust OPFR con-
centrations and the measured metabolites in 
urine (not shown).
Conclusions
Exposure to TDCPP and TPP among adult 
men in the United States is likely common. 
In the present study a high degree of vari-
ability between persons for concentrations 
of TDCPP and TPP in house dust and their 
metabolites in urine was observed, and uri-
nary concentrations of BDCPP and DPP 
were moderately to highly reliable within 
individuals over the course of 3 months. Our 
data suggest that household dust may be an 
important source of exposure to TDCPP but 
not TPP, although more detailed research on 
the exposure sources, pathways and routes of 
exposure to these chemicals is needed. If the 
indoor environment at home is the primary 
source of exposure to OPFRs, measuring con-
centrations in house dust may be a desirable 
approach to assessing long-term exposure to 
these chemicals that are likely metabolized 
and excreted rapidly once entering the body. 
However, concentrations in dust from other 
micro  environments where people spend the 
most time may also need to be considered, 
which would increase the time and costs 
required and may become infeasible in large 
epidemiologic studies. On the other hand, if 
sources of OPFR exposure are multiple and 
varied, exposure biomarkers such as urinary 
metabolites that account for all routes of 
exposure may be the best approach. However, 
knowledge of their utility through a better 
understanding of toxicokinetics, temporal 
variability, and other parameters is needed.
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